GATA6 promotes angiogenic function and survival in endothelial cells by suppression of autocrine transforming growth factor beta/activin receptor-like kinase 5 signaling.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Molkentin, Jeffery D
Wollert, Kai C
MetadataShow full item record
AbstractUnderstanding the transcriptional regulation of angiogenesis could lead to the identification of novel therapeutic targets. We showed here that the transcription factor GATA6 is expressed in different human primary endothelial cells as well as in vascular endothelial cells of mice in vivo. Activation of endothelial cells was associated with GATA6 nuclear translocation, chromatin binding, and enhanced GATA6-dependent transcriptional activation. siRNA-mediated down-regulation of GATA6 after growth factor stimulation led to a dramatically reduced capacity of macro- and microvascular endothelial cells to proliferate, migrate, or form capillary-like structures on Matrigel. Adenoviral overexpression of GATA6 in turn enhanced angiogenic function, especially in cardiac endothelial microvascular cells. Furthermore, GATA6 protected endothelial cells from undergoing apoptosis during growth factor deprivation. Mechanistically, down-regulation of GATA6 in endothelial cells led to increased expression of transforming growth factor (TGF) β1 and TGFβ2, whereas enhanced GATA6 expression, accordingly, suppressed Tgfb1 promoter activity. High TGFβ1/β2 expression in GATA6-depleted endothelial cells increased the activation of the activin receptor-like kinase 5 (ALK5) and SMAD2, and suppression of this signaling axis by TGFβ neutralizing antibody or ALK5 inhibition restored angiogenic function and survival in endothelial cells with reduced GATA6 expression. Together, these findings indicate that GATA6 plays a crucial role for endothelial cell function and survival, at least in part, by suppressing autocrine TGFβ expression and ALK5-dependent signaling.
CitationGATA6 promotes angiogenic function and survival in endothelial cells by suppression of autocrine transforming growth factor beta/activin receptor-like kinase 5 signaling. 2011, 286 (7):5680-90 J. Biol. Chem.
AffiliationMedizinische Hochschule Hannover, Klinik für Kardiologie und Angiologie, Institut für Molekularbiologie, Rebirth-Cluster of Excellence, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
The following license files are associated with this item:
- Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5.
- Authors: Lu Q
- Issue date: 2008 Jul
- Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
- Authors: Shao ES, Lin L, Yao Y, Boström KI
- Issue date: 2009 Sep 3
- Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
- Authors: Ungefroren H, Hyder A, Hinz H, Groth S, Lange H, El-Sayed KM, Ehnert S, Nüssler AK, Fändrich F, Gieseler F
- Issue date: 2015
- Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2.
- Authors: Echeverría C, Montorfano I, Tapia P, Riedel C, Cabello-Verrugio C, Simon F
- Issue date: 2014 Sep
- The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.
- Authors: Sun Z, Schriewer J, Tang M, Marlin J, Taylor F, Shohet RV, Konorev EA
- Issue date: 2016 Jan